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There is an ever-expanding body of clinicallyoriented literature that demonstrates the effi-
cacy of photorejuvenation as a means of enhancing
the appearance of skin.1–5 From traditional fully
ablative laser resurfacing to nonablative laser ther-
apy to fractionated photothermolysis, there is sub-
stantial evidence of efficacy, including a number of
randomized, controlled trials. There have also been
several attempts to objectively measure the effects
of laser therapy using tools such as ultrasound-
based imaging, profilometry, histology, and three-
dimensional imaging.6–9
Almost as important as proving that a specific
treatment is clinically effective is to determine how
that procedure brings about changes in the appear-
ance of skin. Sophisticated cellular and molecular
biology techniques including real-time polymerase
chain reaction technology are now being applied to
the study of the effects of laser therapy on photo-
damaged skin.10–13 The value of taking such a
mechanistic approach to studying photorejuvena-
tion is at least twofold. First, the resulting quantita-
tive data are a purely objective way to demonstrate
and validate the notion that lasers bring about sub-
stantial changes in the structure and function of
skin. This is perhaps most important with less-inva-
sive procedures in which truly objective evidence of
efficacy may be more powerful than purely clinical
but often inherently subjective assessments. Second,
studying the molecular mechanisms whereby lasers
alter skin may serve as the basis for optimization
of laser treatment parameters and protocols. Evalu-
ating objective, quantitative data that measures
molecular dermal and epidermal changes brought
about by various different laser settings may sug-
gest treatment protocols that bring about the great-
est amount of clinical change possible with a given
device. Given the plethora of programmable laser
settings available with many of the most commonly
employed devices, determining optimal treatment
parameters is a daunting task indeed.
There have been some attempts over the past dec-
ade to delineate the mechanisms of photorejuvena-
tion. Although that research is ongoing, an
emerging paradigm suggests that, generally speak-
ing, laser therapy results in an initial inflammatory
stage marked by elevated levels of various cyto-
kines, followed by dermal remodeling, including
induction of several important matrix metallopro-
teinases, and finally upregulation of collagen.10,13
The details of the timing and degree of these
molecular events vary substantially between laser
subtypes, but the basic framework of the controlled
wound healing that results from photorejuvenation
has been demonstrated to be fairly consistent
across a variety of treatment techniques.10–13
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In this issue of Dermatologic Surgery, Lee and
colleagues have reported on their examination of
the molecular events that occur after long-pulsed
neodymium-doped yttrium aluminum garnet (Nd:
YAG) laser therapy.14 Their study included quanti-
fication of matrix metalloproteinase-1 and trans-
forming growth factor beta (TGF-b) levels and a
semiquantitative assessment of dermal collagen
induction. The authors are to be applauded for
their attempt to further delineate the mechanisms
involved with this type of photorejuvenation even
as their study underscores many of the challenges
inherent to this type of work. As noted, dermal
remodeling is a dynamic process requiring evalua-
tion at multiple timepoints to provide a clear pic-
ture of the mechanistic events involved. Thus, the
results reported here simply provide a snapshot of
dermal remodeling occurring at a particular
moment (1 month) after treatment and may serve
as the basis for additional work in this area. In
addition, as the authors point out, it is unclear the
degree to which their model for inducing photo-
damage using ultraviolet light exposure over a brief
time mirrors the kinds of changes seen in chroni-
cally sun-exposed skin, nor is it possible to know
at this point how well murine skin serves as a
model for human skin in this context. Still, the
finding of an association between TGF-b and
collagen induction after exposure to this laser is in
keeping with the idea that TGF-b may play a cru-
cial role in laser-based dermal remodeling, as sug-
gested by previous work.10 Finally, the authors’
evaluation of dermal remodeling after the use of
varying fluences is precisely the type of approach
that may one day help determine optimal treatment
parameters with this laser system.
It is likely that laser therapy will continue to play
an important role in the treatment of many of the
clinical signs of photoaging in the years to come.
As therapeutic options to improve the appearance
of skin evolve, a great deal of clinical, basic, and
translational research will be required to ensure
that we are providing optimal treatments for our
patients.
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